Activist George Haywood Reveals New Biotech TargetMark Melin
“Reluctant activist” investor George Haywood has a new biotech target in his sights.
George Haywood has an unusual career and socially conscious approach to activism. After successfully brokering in the Sirius / XM satellite deal, where he sat on the board for a time, and engaging in activist maneuvers with Sarepta Therapeutics Inc (NASDAQ:SRPT), investing when the biotech firm had a mere $150 . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.